Evidence map›Paper›PMID 31364564›Full record

ArticleEpidemiology and infection2019

Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.

Lorenzo Subissi, Michael Peeters, Sophie Lamoral, Sofieke Klamer, Vanessa Suin, Steven Van Gucht

Abstract readComparative Study
In one paragraph

Article in Epidemiology and infection, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Clinical Burden of Symptomatic HEV-3 Infection in Southern Spain.Alimentary pharmacology & therapeutics · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hepatitis E virus genotype 3 microbiological surveillance by the Spanish Reference Laboratory: geographic distribution and phylogenetic analysis of subtypes from 2009 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lorenzo SubissiNational Reference Centre of Hepatitis Viruses, Sciensano,Brussels,Belgium.
Michael PeetersNational Reference Centre of Hepatitis Viruses, Sciensano,Brussels,Belgium.
Sophie LamoralNational Reference Centre of Hepatitis Viruses, Sciensano,Brussels,Belgium.
Sofieke KlamerEpidemiology of Infectious Diseases, Sciensano,Brussels,Belgium.
Vanessa SuinNational Reference Centre of Hepatitis Viruses, Sciensano,Brussels,Belgium.
Steven Van GuchtNational Reference Centre of Hepatitis Viruses, Sciensano,Brussels,Belgium.ORCID 0000-0002-8150-9372

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some European countries recently reported an increase in hepatitis E virus genotype 3 (HEV-3) of the subtype 3c. No link between HEV-3 subtypes and severity is established to date. Here, we report that patients infected with HEV-3c were at lower risk of hospitalisation, compared to those infected with HEV-3f, the other main subtype circulating in Belgium.

Indexed as

Hospital MortalityRegistriesAdultAgedAge FactorsAnimalsBelgiumConfidence IntervalsFemaleGenotypeHepatitis EHepatitis E virusHospitalizationHumansMaleMiddle AgedFood-borne infectionshepatitisinfectious disease epidemiologymolecular epidemiologyzoonotic foodborne diseases

Identifiers

PMID31364564
PMCPMC6625206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.